|
Agenda |
|
|
 |
| Conference Highlights |
Topics to include:
- Special look at how the 340B and Medicaid rebate programs will be impacted by a new President and Congress
- Legislation to improve integrity of 340B program and to expand program discounts to new entities and inpatient drugs
- Fate of government’s proposed changes to 340B definition of patient—will tighter restrictions be applied to record keeping, home care, patient referrals, outside prescribers and discharge prescriptions?
- Increased enforcement against 340B overcharging and possibility of more litigation as a result of new federal court decision
- More changes to Average Manufacturer Price due to pending litigation and legislation—what are the implications for 340B program?
- Update on government's proposal to expand the use of contract pharmacies in 340B program
- Update on expansion of 340B program to children's hospitals
- Small roundtables to address specific needs of attendees including guidance on inventory management, Medicaid billing, AMP changes, NDC reporting, contract pharmacies, patient definition, and prime vendor program
- Status of legislation to increase Medicaid rebates and 340B discount
|
|
| |
Conference Attire: Business Casual
Continuing Education Credits for Pharmacists will be Available! |
|
|
|
